Neonatal symptoms following maternal paroxetine treatment: Serotonin toxicity or paroxetine discontinuation syndrome?

Journal of Psychopharmacology

Volumn 19, Issue 5, 2005, Pages 554-557

  Haddad, Peter M ^a,d   Pal, B R ^b   Clarke, P ^b   Wieck, A ^c   Sridhiran, S ^a  

^a GREATER MANCHESTER MENTAL HEALTH NHS FOUNDATION TRUST   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

^c WYTHENSHAWE HOSPITAL   (United Kingdom)

^d Cromwell House   (United Kingdom)

Author keywords

Antidepressants; Neonate; Pregnancy; Selective serotonin reuptake inhibitors; Serotonin syndrome; Withdrawal syndrome

Indexed keywords

CHLORPROMAZINE; MIDAZOLAM; PAROXETINE; PHENOBARBITAL; SEROTONIN UPTAKE INHIBITOR;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; CONVULSION; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DRUG BLOOD LEVEL; DRUG SURVEILLANCE PROGRAM; FEMALE; FEVER; FOLLOW UP; HUMAN; HYPERREFLEXIA; IRRITABILITY; LABORATORY TEST; MUSCLE HYPERTONIA; NEONATAL RESPIRATORY DISTRESS SYNDROME; NEWBORN; OPISTHOTONUS; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SEIZURE; SEROTONIN SYNDROME; WITHDRAWAL SYNDROME;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DEPRESSIVE DISORDER; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INFANT, NEWBORN; NEONATAL ABSTINENCE SYNDROME; PAROXETINE; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 25844504156     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881105056554     Document Type: Article

References (22)

1. Australian Adverse Drug Reactions Advisory Committee (1996) SSRIs and withdrawal syndrome. Aust Adv Drug React Bull 15: 3
2. Chambers C D, Johnson B A, Dick L M et al. (1996) Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 335: 1010-1015
3. Chung T K H, Lau T K, Yip A S K, Chiu H F K, Lee D T S (2001) Antepartum depressive symptomatology is associated with adverse obstetric and neonatal outcomes. Psychosom Med 63(5): 830-834
4. Cowe L, Lloyd D J, Dawling S (1982) Neonatal convulsions caused by withdrawal from maternal clomipramine. Br Med J (Clin Res Ed) 254: 1837-1838
5. Dahl M L, Olhager E, Ahlner J (1997) Paroxetine withdrawal syndrome in a neonate. Br J Psychiatry 171: 391-392
6. D'Arcy P F (1993) Dystonia and withdrawal symptoms with paroxetine (letter). Int Pharm J 7: 140
7. Finnegan L P, Connaughton J F Jr, Kron R E, Emich J P (1975) Neonatal abstinence syndrome: assessment and management. Addict Dis 2: 141-158
8. Gillman K, Whyte, I M (2004) Serotonin syndrome (chapter 3). In Haddad P, Dursun S, Deakin B (eds), Adverse Syndromes and Psychiatric Drugs: A Clinical Guide. Oxford University Press, Oxford, pp. 37-49
9. Haddad P (1998) The SSRI discontinuation syndrome. J Psychopharmacol 12(3): 305-313
10. Haddad P M (2001) Antidepressant discontinuation syndromes: clinical relevance, prevention and management. Drug Safety 24: 183-197
11. Kent L S W, Laidlaw J D D (1995) Suspected congenital sertraline dependence (letter). Br J Psychiatry 167: 412-413
12. Laine K, Heikkinen T, Ekblad U, Kero P (2003) Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry 60: 720-726
13. Lane R, Baldwin D (1997) Selective serotonin reuptake inhibitor-induced serotonin syndrome: review. J Clin Psychopharmacol 17: 208-221
14. Michelson D, Fava M, Amsterdam J et al. (2000) Interruption of selective serotonin reuptake inhibitor treatment: double-blind, placebo-controlled trial. Br J Psychiatry 176: 363-368
15. Misri S, Sivertz K (1991) Tricyclic drugs in pregnancy and lactation: a preliminary report. Int J Psychiatry Med 21: 157-571
16. Nijhuis I J M, Kok-Van Rooji G W M, Bosschaart A N (2001) Withdrawal reactions of a premature neonate after maternal use of paroxetine. Arch Dis Child Fetal Neonatal Ed 84: F77
17. Nordeng H, Lindemann R, Perminov K V et al. (2001) Neonatal withdrawal syndrome after in utero exposure to selective serotonin reuptake inhibitors. Acta Paediatr 90(3): 288-291
18. Stoukides J A, Stoukides C A (1991) Extrapyramidal symptoms upon discontinuation of fluoxetine (letter). Am J Psychiatry 148(9): 1263
19. Stiskal J A, Kulin N, Koren G, Ho T, Ito S (2001) Neonatal paroxetine withdrawal syndrome. Arch Dis Child Fetal Neonatal Ed 84: F134-F135
20. Zeskind P S, Stephens L S (2004) Maternal selective reuptake inhibitor use during pregnancy and newborn neurobehavior. Pediatrics 113: 368-375
21. Zuckerman B, Amaro H, Bauchner H, Cabral H (1989) Depressive symptoms during pregnancy: relationship to poor health behaviours. Am J Obstet Gynecol 160: 1107-1111
22. Zuckerman B, Bauchner H, Parker S, Cabral H (1990) Maternal depressive symptoms during pregnancy, and newborn irritability. J Dev Behav Pediatr 11: 190-194